Document is current
Any future updates will be listed below
-
Authors
Herzig-Nichtweiß, Julia https://orcid.org/0000-0002-5365-8231
Salih, Farid https://orcid.org/0000-0003-1114-3181
Berning, Sascha
Malter, Michael P. https://orcid.org/0000-0003-2535-4553
Pelz, Johann O. https://orcid.org/0000-0003-4391-2280
Lochner, Piergiorgio https://orcid.org/0000-0002-2101-6066
Wittstock, Matthias https://orcid.org/0000-0001-9904-6436
Günther, Albrecht https://orcid.org/0000-0002-2394-3947
Alonso, Angelika https://orcid.org/0000-0003-2487-7205
Fuhrer, Hannah https://orcid.org/0000-0002-5663-8033
Schönenberger, Silvia https://orcid.org/0000-0002-3348-6719
Petersen, Martina
Kohle, Felix https://orcid.org/0000-0002-4429-0367
Müller, Annekatrin https://orcid.org/0000-0001-8007-6846
Gawlitza, Alexander
Gubarev, Waldemar
Holtkamp, Martin https://orcid.org/0000-0003-2258-1670
Vorderwülbecke, Bernd J. https://orcid.org/0000-0002-0528-4001
,
-
Funding
Funding for this research was provided by:
Deutsche Gesellschaft für Neurointensiv- und -Notfallmedizin DGNI (Young Researcher Promotion Award, 2020)
Medizinische Fakultät der Albert-Ludwigs-Universität Freiburg (Clinical Studies Program, 3091332005)
Faculty of Medicine, University of Cologne (Köln Fortune Program, 472/2020)
v. Bodelschwingh Foundation
Deutsche Forschungsgemeinschaft (DFG 422589384)
Deutsche Gesellschaft für Epileptologie (Otfrid Foerster scholarship, 2021)
Charité - Universitätsmedizin Berlin
- License Information
-
More Information
Article History
Received: 22 May 2023
Accepted: 1 September 2023
First Online: 15 September 2023
Declarations
:
: The study was approved by the leading ethics committee at Charité – Universitätsmedizin Berlin (EA2/016/19) and by the recruiting centers’ local ethics committees. All participants or legal guardians gave written informed consent.
: Not applicable.
: JHN received a travel allowance from Eisai; FS received speaker’s honoraria from Ameos, AstraZeneca, Bristol-Myers Squibb, and MD Horizonte; MW received speaker’s honoraria and consultancy fees from Portola/Alexion; AG received speaker’s honoraria from Boehringer Ingelheim, Daiichi Sankyo, Ipsen, Occlutech, and Pfizer, as well as research grants from Merz and Ipsen; MH received speaker’s honoraria and/or consultancy fees from Angelini, Bial, Desitin, Eisai, Jazz, Neuraxpharm, UCB, and Zogenix. All other authors declare that they have no competing interests.
